RESUMEN
In this work, the in vitro anti-Leishmania activity of photodynamic liposomes made of soybean phosphatidylcholine, sodium cholate, total polar archaeolipids (TPAs) extracted from the hyperhalophile archaea Halorubrum tebenquichense and the photosensitizer zinc phthalocyanine (ZnPcAL) was compared to that of ultradeformable photodynamic liposomes lacking TPAs (ZnPcUDLs). We found that while ZnPcUDLs and ZnPcALs (130 nm mean diameter and -35 mV zeta potential) were innocuous against promastigotes, a low concentration (0.01 µM ZnPc and 7.6 µM phospholipids) of ZnPcALs irradiated at a very low-energy density (0.2 J/cm(2)) eliminated L. braziliensis amastigotes from J774 macrophages, without reducing the viability of the host cells. In such conditions, ZnPcALs were harmless for J774 macrophages, HaCaT keratinocytes, and bone marrow-derived dendritic cells. Therefore, topical photodynamic treatment would not likely affect skin-associated lymphoid tissue. ZnPcALs were extensively captured by macrophages, but ZnPcUDLs were not, leading to 2.5-fold increased intracellular delivery of ZnPc than with ZnPcUDLs. Despite mediating low levels of reactive oxygen species, the higher delivery of ZnPc and the multiple (caveolin- and clathrin-dependent plus phagocytic) intracellular pathway followed by ZnPc would have been the reason for the higher antiamastigote activity of ZnPcALs. The leishmanicidal activity of photodynamic liposomal ZnPc was improved by TPA-containing liposomes.
Asunto(s)
Antiprotozoarios/farmacología , Éteres de Glicerilo/farmacología , Indoles/farmacología , Leishmania/efectos de los fármacos , Leishmania/efectos de la radiación , Liposomas/farmacología , Compuestos Organometálicos/farmacología , Animales , Antiprotozoarios/química , Antiprotozoarios/farmacocinética , Antiprotozoarios/toxicidad , Línea Celular , Supervivencia Celular/efectos de los fármacos , Éteres de Glicerilo/química , Éteres de Glicerilo/farmacocinética , Éteres de Glicerilo/toxicidad , Humanos , Indoles/química , Indoles/farmacocinética , Indoles/toxicidad , Isoindoles , Liposomas/química , Liposomas/farmacocinética , Liposomas/toxicidad , Macrófagos/metabolismo , Ratones , Compuestos Organometálicos/química , Compuestos Organometálicos/farmacocinética , Compuestos Organometálicos/toxicidad , Especies Reactivas de Oxígeno/análisis , Especies Reactivas de Oxígeno/metabolismo , Compuestos de ZincRESUMEN
Alkyl glyceryl ethers function mostly as skin-conditioning agents in cosmetic products applied to the skin and hair. The Cosmetic Ingredient Review expert panel reviewed the available animal toxicity and clinical data, including the low dermal absorption, and concluded that the alkyl glyceryl ethers are safe in the present practices of use and concentration described in this safety assessment.
Asunto(s)
Éteres de Glicerilo/toxicidad , Animales , Seguridad de Productos para el Consumidor , Cosméticos , Éteres de Glicerilo/química , Éteres de Glicerilo/farmacocinética , HumanosRESUMEN
Butyric acid has been the subject of much attention last years due to its bioactivity. However, the potential advantages of butyrate are limited by the problem to reach enough plasma concentrations; therefore, pro-drugs have been proposed as an alternative to natural butyrate. A comparative study on in vitro intestinal digestion of 2,3-dibutyroil-1-O-octadecyl glycerol (D-SCAKG) and tributyrin (TB), as potential pro-drugs of butyric acid, was performed. Aliquots were taken at different times of digestion for studying the extent and rate of hydrolysis of both substrates. The micellar phase (MP) and oily phase (OP) formed in the digestion media were separated and their composition in lipid products was analyzed. Initially, it was confirmed that the in vitro model reproduced physiological results by testing against olive oil as a standard lipid. The progress of in vitro intestinal digestion of D-SCAKG was slower than that of TB. TB hydrolyzed completely to butyric acid, whereas D-SCAKG mainly yielded 2-butyroil-1-O-octadecyl glycerol (M-SCAKG), followed by butyric acid and 1-O-octadecyl glycerol (AKG). The MP from both substrates mainly consisted of butyric acid. Minor levels of M-SCAKG and AKG were also found in the MP after hydrolysis of D-SCAKG, the M-SCAKG being mainly distributed in the OP. Therefore, D-SCAKG produced a stable form of esterified butyric acid as M-SCAKG after in vitro intestinal digestion, unlike TB. Additionally, such a product would integrate both bioactive compounds, butyric acid and alkylglycerol, within the same molecule. Free butyric acid and AKG would be also released, which are lipid products of interest as well.
Asunto(s)
Ácido Butírico/administración & dosificación , Glicerol/farmacocinética , Mucosa Intestinal/metabolismo , Vehículos Farmacéuticos/farmacocinética , Triglicéridos/farmacocinética , Disponibilidad Biológica , Ácido Butírico/química , Ácido Butírico/farmacocinética , Digestión/fisiología , Diglicéridos/química , Diglicéridos/farmacocinética , Composición de Medicamentos , Éteres de Glicerilo/química , Éteres de Glicerilo/farmacocinética , Humanos , Hidrólisis , Técnicas In Vitro , Modelos Biológicos , Triglicéridos/químicaRESUMEN
1 The intracarotid administration of alkylglycerols has been reported previously by us to be a novel strategy for increased delivery of various chemotherapeutic drugs to the normal brain and brain tumors in rats. 2 Effectiveness and structure-activity relations of the most promising pentyl- and hexylglycerol derivatives have been elucidated in vivo by analyzing the transfer of methotrexate (MTX) across the blood-brain barrier (BBB) in normal rats. The effects were compared with BBB disruption using hypertonic mannitol or intracarotid infusion of bradykinin. Furthermore, toxicity of the alkylglycerols has been studied in long-term experiments. 3 Apart from 1-O-pentyldiglycerol, all alkylglycerols induced a concentration-dependent increase in MTX delivery to the brain varying from 1.1 to more than 300-fold compared to intra-arterial MTX alone. Enhanced barrier permeability rapidly approached baseline values within 5 and 120 min at the latest. Chemical structure, concentration, time schedule of injections and combination of different alkylglycerols were identified as instruments suited to regulate the MTX accumulation within a wide range. Mannitol 1.4 M resulted in very high MTX levels in the brain as observed using the highest concentrations of alkylglycerols. Intracarotid infusion of bradykinin had only a minor effect on the BBB. Using 1-O-pentylglycerol or 2-O-hexyldiglycerol, both cell culture experiments and long-term in vivo analyses including clinical, laboratory and histopathological evaluations revealed no signs of toxicity. 4 In summary, intracarotid short-chain alkylglycerols constitute a very effective and low toxic strategy for transient opening of the BBB to overcome the limited access of cytotoxic drugs to the brain.
Asunto(s)
Barrera Hematoencefálica/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Glicerol/análogos & derivados , Glicerol/administración & dosificación , Glicerol/farmacocinética , Éteres de Glicerilo/administración & dosificación , Éteres de Glicerilo/farmacocinética , Metotrexato/farmacocinética , Animales , Barrera Hematoencefálica/fisiopatología , Bradiquinina/administración & dosificación , Bradiquinina/farmacocinética , Encéfalo/ultraestructura , Arterias Carótidas , Línea Celular Tumoral , Relación Dosis-Respuesta a Droga , Portadores de Fármacos , Sinergismo Farmacológico , Quimioterapia Combinada , Femenino , Glicerol/química , Humanos , Inyecciones Intraarteriales , Masculino , Manitol/administración & dosificación , Manitol/farmacocinética , Metotrexato/administración & dosificación , Metotrexato/química , Monocitos/efectos de los fármacos , Permeabilidad , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Relación Estructura-Actividad , Factores de Tiempo , Vena Cava SuperiorRESUMEN
En la última década se ha avanzado notablemente en la utilización de los promotores de la absorción para su inclusión en formas farmacéuticas de fármacos débilmente absorbidos. El presente trabajo desarrolla la evaluación in vitro de un éter de glicerilo de origen marino, frente a otros promotores reconocidos internacionalmente. Se ralizan experiencias de perfil cinético de transferencia, estudios de regeneración de la permeabilidad de la membrana, así como estudios de microscopia electrónica para definir daño celular. Los resultados demuestran la potencialidad de esta sustancia como promotor de la absorción, de rápida regeneración del comportamiento de la biomembrana, así como a diferencias con respecto a otros promotores, no ocasionó daño celular (AU)
Asunto(s)
Absorción , Éteres de Glicerilo/farmacocinéticaRESUMEN
En la última década se ha avanzado notablemente en la utilización de los promotores de la absorción para su inclusión en formas farmacéuticas de fármacos débilmente absorbidos. El presente trabajo desarrolla la evaluación in vitro de un éter de glicerilo de origen marino, frente a otros promotores reconocidos internacionalmente. Se ralizan experiencias de perfil cinético de transferencia, estudios de regeneración de la permeabilidad de la membrana, así como estudios de microscopia electrónica para definir daño celular. Los resultados demuestran la potencialidad de esta sustancia como promotor de la absorción, de rápida regeneración del comportamiento de la biomembrana, así como a diferencias con respecto a otros promotores, no ocasionó daño celular
Asunto(s)
Absorción , Éteres de Glicerilo/farmacocinéticaRESUMEN
Membrane-interactive ether lipids (EL) exert toxic and antiproliferative effects on cancer cells in vitro. They appear to be selectively more toxic to cancer cells than to normal cells and thus they are ideal candidates for bone-marrow purging procedures. However, no conclusive explanation has yet been provided for this property. We now present some data indicating that the cholesterol concentration in the incubation medium modulates EL toxicity against the HL60 leukemic cell line in vitro. Furthermore, model membranes richer in cholesterol take up EL more slowly, and cell cholesterol enrichment of HL60 cells counteracts EL biophysical membrane interaction, but not toxicity, in our experimental model. However, the K562 cell line, a leukemia line less sensitive to EL toxic action, has higher levels of cell cholesterol. Our data provide evidence to explain differences in sensitivity to EL among different cell types and contribute to the understanding of the mechanism of action of EL.
Asunto(s)
Antineoplásicos/farmacocinética , Membrana Celular/metabolismo , Colesterol/metabolismo , Éteres de Glicerilo/farmacocinética , Ácidos Fosfatidicos/farmacocinética , Antineoplásicos/toxicidad , Línea Celular , Membrana Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Éteres de Glicerilo/toxicidad , Humanos , Leucemia/metabolismo , Fluidez de la Membrana/efectos de los fármacos , Ácidos Fosfatidicos/toxicidad , Factores de Tiempo , Células Tumorales Cultivadas/efectos de los fármacos , Células Tumorales Cultivadas/metabolismoRESUMEN
1-O-methyl-rac-glycerol (1-O-MG), also known as 3-methoxy-1,2-propanediol is a lipophilic derivative of glycerol, and has been studied as a new cryoprotective agent (CPA) for mononuclear blood cells (MNC), a well-established experimental model in cryopreservation. The chemical modification of the glycerol molecule results in improved cryobiological properties, such as membrane permeability, thus allowing easier handling in the freeze/thaw process. The optimum preincubation period for MNC and 1-O-MG before freezing is 5 min at 4 degree C, resulting in 86% recovery of viable cells, whereas optimal recovery of glycerol-frozen MNC is only guaranteed after 30 min of preincubation at room temperature (74% viable recovery). The optimal concentration of 1-O-MG is 10% (v/v). Although this new agent offers no improvement in cryoprotective properties over dimethyl sulfoxide (Me2SO) there may be possible pharmacological advantages when used in humans. It is, however, obviously superior to glycerol with regard to its permeation kinetics. 1-O-MG might therefore also be of interest in the cryoprotection of other hematopoietic cells and biological tissues.
Asunto(s)
Conservación de la Sangre/métodos , Crioprotectores , Éteres de Glicerilo , Leucocitos Mononucleares , Permeabilidad de la Membrana Celular , Supervivencia Celular , Dimetilsulfóxido , Congelación , Glicerol , Éteres de Glicerilo/síntesis química , Éteres de Glicerilo/farmacocinética , Humanos , Técnicas In Vitro , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/metabolismoRESUMEN
We have investigated cellular sensitivity to the antitumoral alkyl lysophospholipid (ALP) 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine (ET-18-OCH3) in vitro. The permeation of this lipid into the cell was not influenced by metabolic inhibitors of ATP biosynthesis. ET-18-OCH3 uptake was not saturable within sublytic concentrations, but could be inhibited in part by cytochalasin B (CB) and dipyridamole. The activation energy of the CB-sensitive uptake process was increased up to threefold compared to CB-insensitive uptake. ET-18-OCH3 influx and equilibrium binding of ET-18-OCH3 were decreased in a fibrosarcoma cell variant (MethA) selected for ET-18-OCH3 resistance. The resistant MethA cells were also less sensitive to cytolysis by lysophosphatidylcholine and other ALP. After 72 hr, the resistant MethA cells had metabolized only 11.8% more of the absorbed ET-18-OCH3 than sensitive MethA cells. However, they tolerated at least a 30-fold concentration of this ALP. The uptake mechanism, which could be inhibited by CB, was less active in resistant MethA cells and several other ALP-resistant cell lines. The concentration of CB, required for maximal uptake inhibition, was increased more than four times in the ALP-sensitive tumor cell lines. CB-specific ET-18-OCH3 uptake was also enhanced after virus transformation of 3T3 fibroblasts by SV 40. Dipyridamole retarded the ET-18-OCH3-mediated cell destruction.
Asunto(s)
Permeabilidad de la Membrana Celular/efectos de los fármacos , Citotoxinas/farmacocinética , Éteres de Glicerilo/farmacocinética , Lisofosfolípidos/farmacocinética , Células Tumorales Cultivadas/efectos de los fármacos , Animales , Antineoplásicos/farmacocinética , Antineoplásicos/farmacología , Línea Celular , Citocalasina B/farmacología , Citotoxinas/farmacología , Dipiridamol/farmacología , Éteres de Glicerilo/farmacología , Lisofosfolípidos/farmacología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Éteres Fosfolípidos/farmacocinética , Éteres Fosfolípidos/farmacologíaRESUMEN
Tumor cells grown in the presence of 1-O-alkyl-2-O-methylglycero-3-phosphocholine (AMG-PC) accumulated this ether lipid in their membranes. Depending on the cell type and the dose of the compound, up to 17% of the total phospholipids of the purified plasma membranes consisted of authentic AMG-PC. Extensive incorporation of the agent resulted in a decrease in plasma membrane fluidity and inhibition of tumor cell invasiveness in embryonic chick heart fragments. The extent of AMG-PC incorporation and fluidity change was not strictly correlated with the degree to which tumor cell invasion was inhibited.